Concerns over safety of Alzheimer’s drug after death of patient

TORONTO: Concerns about safety risks of the controversial new Alzheimer’s drug Aduhelm have intensified in…

To read the full content…SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In